用多化合物进行辅助性抗瘤治疗:一篇评论
Ilgiz Gareev1, Jianhao Jiang2,3, Ozal Beylerli1
1Central Research Laboratory, Department of Pharmacology, Bashkir State Medical University, Republic of Bashkortostan, 3 Lenin Street, Ufa, 450008, Russia.
天然和合成的多醇通过增加瘤中的氧化应激,减少对化疗和放射治疗的抗性来增强癌症治疗. 它们还保护正常组织免受治疗副作用的影响.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
背景情况:
- 化疗和放射治疗通过通过活性氧物种 (ROS) 诱导细胞死亡来对抗癌症.
- 增加瘤细胞中的氧化应激是一种提高抗癌疗法有效性的策略.
- 聚醇正在成为癌症治疗中的有希望的辅助剂.
研究的目的:
- 探索多在癌症治疗中的分子机制和临床应用.
- 评估多在降低瘤细胞抵抗化疗和放射治疗中的作用.
- 研究聚醇对正常组织治疗诱导毒性的保护作用.
主要方法:
- 对癌症治疗中多的临床前和临床研究的文献综述.
- 分析涉及多介导氧化应激和细胞反应的分子通路.
- 检查了与化疗和放射治疗结合使用多的疗效数据.
主要成果:
- 聚醇表现出抗瘤活性,并增强对化疗和放射治疗的敏感性.
- 天然和合成的多可以减轻癌症治疗对健康组织的有毒副作用.
- 聚醇在管理与治疗相关的毒性方面显示出潜力,改善患者的生活质量.
结论:
- 多化合物在瘤学中具有双重益处:增强抗癌疗法的疗效和改善治疗诱导的毒性.
- 需要对多进行进一步的临床研究,以便将其纳入标准的癌症治疗方案.
- 多是一种有前途的治疗策略,可以改善接受化疗和放射治疗的癌症患者的治疗结果.
更多相关视频
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
相关概念视频
Drugs that Stabilize Microtubules
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
